EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Anemia From Inflammation After Intracerebral Hemorrhage and Relationships With Outcome

David J Roh iD, Fernanda Carvalho Poyraz, Eric Mao iD, Qi Shen, Vedant Kansara, Azzurra Cottarelli iD, Sandy Song, Travis Nemkov, Aditya Kumar iD, Krystalyn E Hudson iD, Shivani Ghoshal, Soojin Park iD und 8 weitere

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.035524 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von David J Roh und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Vagelos College of Physicians and Surgeons Columbia University New York City NY USA. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Anemia, Biomarkers, Hemoglobins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Baseline anemia is associated with poor intracerebral hemorrhage (ICH) outcomes. However, underlying drivers for anemia and whether anemia development after ICH impacts clinical outcomes are unknown. We hypothesized that inflammation drives anemia development after ICH and assessed their relationship to outcomes. Methods and Results Patients with serial hemoglobin and iron biomarker concentrations from the HIDEF (High‐Dose Deferoxamine in Intracerebral Hemorrhage) trial were analyzed. Adjusted linear mixed models assessed laboratory changes over time. Of 42 patients, significant decrements in hemoglobin occurred with anemia increasing from 19% to 45% by day 5. Anemia of inflammation iron biomarker criteria was met in 88%. A separate cohort of 521 patients with ICH with more granular serial hemoglobin and long‐term neurological outcome data was also investigated. Separate regression models assessed whether (1) systemic inflammatory response syndrome (SIRS) scores related to hemoglobin changes over time and (2) hemoglobin changes related to poor 90‐day outcome. In this cohort, anemia prevalence increased from 30% to 71% within 2 days of admission yet persisted beyond this time. Elevated systemic inflammatory response syndrome was associated with greater hemoglobin decrements over time (adjusted parameter estimate: −0.27 [95% CI, −0.37 to −0.17]) and greater hemoglobin decrements were associated with poor outcomes (adjusted odds ratio per 1 g/dL increase, 0.76 [95% CI, 0.62–0.93]) independent to inflammation and ICH severity.

Conclusions

We identified novel findings that acute anemia development after ICH is common, rapid, and related to inflammation. Because anemia development is associated with poor outcomes, further work is required to clarify if anemia, or its underlying drivers, are modifiable treatment targets that can improve ICH outcomes. Registration https://www.clinicaltrials.gov Unique identifier: NCT01662895

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral HemorrhageAnemiaBiomarkersHemoglobinsInflammationHumansMaleFemaleAgedMiddle AgedSystemic Inflammatory Response SyndromeDeferoxamineTime FactorsTreatment OutcomeIronPrevalence

Stichwörter der Autor:innen

anemiadeferoxaminehemoglobininflammationintracerebral hemorrhageironoutcome

Substanzen

BiomarkersHemoglobinsDeferoxamineIron

Autor:innen und Institutionen

  • Department of Neurology Vagelos College of Physicians and Surgeons Columbia University New York City NY USA.
  • Department of Pathology and Cell Biology Vagelos College of Physicians and Surgeons Columbia University New York City NY USA.
  • Department of Biochemistry and Molecular Genetics University of Colorado Denver Anschutz Medical Campus Aurora CO USA.
  • Department of Neurological Surgery Vagelos College of Physicians and Surgeons Columbia University New York City NY USA.
  • Versiti Blood Research Institute Versiti; Department of Medicine Division of Hematology and Oncology Medical College of Wisconsin Milwaukee WI USA.
  • Department of Public Health Sciences Medical University of South Carolina Charleston SC USA.

ORCID-Profile: David J Roh, Eric Mao, Azzurra Cottarelli, Aditya Kumar, Krystalyn E Hudson, Soojin Park, Jan Claassen, Lisa Baumann Kreuziger, Eldad Hod, Sharon Yeatts, Lydia D Foster, Magdy Selim

Förderung

  • NINDS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Roh, D. J., Poyraz, F. C., Mao, E., Shen, Q., Kansara, V., Cottarelli, A., Song, S., Nemkov, T., Kumar, A., Hudson, K. E., Ghoshal, S., Park, S., Agarwal, S., Connolly, E. S., Claassen, J., Kreuziger, L. B., Hod, E., Yeatts, S., Foster, L. D., & Selim, M. (2024). Anemia From Inflammation After Intracerebral Hemorrhage and Relationships With Outcome. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035524

Vancouver

Roh DJ, Poyraz FC, Mao E, Shen Q, Kansara V, Cottarelli A, et al. Anemia From Inflammation After Intracerebral Hemorrhage and Relationships With Outcome. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035524

BibTeX
@article{Roh2024,
  author = {Roh, David J and Poyraz, Fernanda Carvalho and Mao, Eric and Shen, Qi and Kansara, Vedant and Cottarelli, Azzurra and Song, Sandy and Nemkov, Travis and Kumar, Aditya and Hudson, Krystalyn E and Ghoshal, Shivani and Park, Soojin and Agarwal, Sachin and Connolly, Edward Sander and Claassen, Jan and Kreuziger, Lisa Baumann and Hod, Eldad and Yeatts, Sharon and Foster, Lydia D and Selim, Magdy},
  title = {Anemia From Inflammation After Intracerebral Hemorrhage and Relationships With Outcome},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.035524}
}
Kostenlos starten →